oral semaglutide novo nordisk says works in diabetic kids Here's Novo Nordisk's First Oral FDA accepts filing application for

Introduction Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) represent one of the most transformative pharmacologic developments in metabolic medicine

These typically involve subcutaneous injection into the abdomen, thigh, or upper arm using a prefilled pen device

The medication ships in temperature-controlled packaging to maintain the cold chain during transit

One vial, two or more peptides A peptide blend is a single vial containing two or more peptides in a fixed ratio, reconstituted together in bacteriostatic water

[Epub ahead of print] Posted September 22, 2016

In the meantime, perpetuating the idea that anyone trying to live longer should try GLP-1s can actually be dangerous